Small Molecule for Neuro Indications
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
54
NCT06411912
A Study of NIDO-361 in Patients With SBMA
Phase: Phase 2
Role: Lead Sponsor
Start: Mar 1, 2024
Completion: Oct 1, 2025
Loading map...